Keeler & Nadler Financial Planning & Wealth Management’s AbbVie ABBV Stock Holding History

Keeler & Nadler Financial Planning & Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$290K	Buy	1,153 +90	+8%	+$19.4K	0.08%	71
2026 Q1	$231K	Sell	1,063 -106	-9%	-$23.5K	0.08%	79
2025 Q4	$267K	Hold	1,169	–	–	0.09%	68
2025 Q3	$271K	Buy	1,169 +19	+2%	+$3.87K	0.1%	67
2025 Q2	$214K	Buy	1,150 +3	+0.3%	+$558	0.09%	72
2025 Q1	$235K	Buy	1,147 +1	+0.1%	+$194	0.11%	65
2024 Q4	$204K	Sell	1,146 -1	-0.1%	-$184	0.1%	68
2024 Q3	$226K	Buy	+1,147	New	+$214K	0.11%	64
2024 Q2	–	Sell	-1,125	Closed	-$205K	–	65
2024 Q1	$205K	Buy	+1,125	New	+$194K	0.12%	63

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Keeler & Nadler Financial Planning & Wealth Management's ABBV Position: Q2 2026 in Review

Keeler & Nadler Financial Planning & Wealth Management increased its AbbVie (ABBV) stake by 8.5% in Q2 2026, buying an estimated $19.4K and bringing the position to 1,153 shares worth $290K. The position accounts for 0.08% of the portfolio, ranked #71.

Keeler & Nadler Financial Planning & Wealth Management first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Keeler & Nadler Financial Planning & Wealth Management held 1,153 shares of AbbVie worth $290K as of Q2 2026.
Keeler & Nadler Financial Planning & Wealth Management bought 90 AbbVie shares in Q2 2026, an estimated $19.4K.
AbbVie made up 0.08% of Keeler & Nadler Financial Planning & Wealth Management's portfolio in Q2 2026, its #71 holding.
Keeler & Nadler Financial Planning & Wealth Management first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Keeler & Nadler Financial Planning & Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.